|
|
Archived Abstracts
Abstracts
Results returned = 199
Displaying page 1 of 20
Routine use of platelet components prepared with photochemical treatment impact on clinical outcomes and resources
JC Osselaer, C Doyen, N Messe, M Van Hooydonk, M Jacquet, A Sonnet, A Bosly, J Flament, L Corash
Presented at American Society of Hematology (ASH) 47th Annual Meeting, December 10, 2005 - December 13, 2005
[ View Abstract]
Leucocyte-reduced buffy coat platelet concentrates treated with INTERCEPT stored up to 7 days studied for hemostatic function in a whole blood flow system
M Lozano, A Galan, R Mazzara, L Corash, Gines Escolar
Presented at American Society of Hematology (ASH) 47th Annual Meeting, December 10, 2005 - December 13, 2005
[ View Abstract]
[ Download Poster PDF]
Validation studies in European blood centers to evaluate processing whole-blood derived or apheresis plasma using the INTERCEPT blood system intended for commercialization.
T Hervig, P Schlenke, JP Cazenave, L Pinkoski, Y Singh, L Corash
Presented at American Society of Hematology (ASH) 47th Annual Meeting, December 10, 2005 - December 13, 2005
[ View Abstract]
[ Download Poster PDF]
Antibodies to S-303 treated RBC prepared with the original treatment process for pathogen inactivation do not react with RBC prepared with a modifi ed S-303 treatment process
M Conlan, G Garratty, G Castro, A Erickson, MA Schott, P Arndt, D Cook, L Corash, A Stassinopoulos
Presented at American Society of Hematology (ASH) 47th Annual Meeting, December 10, 2005 - December 13, 2005
[ View Abstract]
The efficacy of photochemical treatment with amotosalen and UVA for inactivation of T. cruzi in buffy coat platelet components
E Castro, N Giron?s, JL Bueno, J Carri?n, M Fresno
Presented at American Society of Hematology (ASH) 47th Annual Meeting, December 10, 2005 - December 13, 2005
[ View Abstract]
[ Download Poster PDF]
Process Validation Studies of the INTERCEPT Blood System for Plasma in Three European Blood Centers
Pinkoski, L, Cazenave, JP, Hervig, T, Schlenke, P, Corash, L
Presented at 22nd Congress of the Society of French Transfusion Sanguine (SFTS) 2005, June 27, 2005 - June 30, 2005
[ View Abstract]
[ Download Poster PDF]
Pilot study with Intercept treated buffy coat derived platelet concentrates
Miguel Lozano, et al
Presented at 22nd Congress of the Society of French Transfusion Sanguine (SFTS) 2005, June 27, 2005 - June 30, 2005
[ View Abstract]
Comparative efficacy of bacterial culture versus pathogen inactivation to reduce the risk of transfusion-associated sepsis.
C. Lass-Florl MD, D. Allersdorfer, M. Rheinschmidt, L. Lin PhD, D. Schonitzer MD and W. Nussbaumer MD
Presented at 22nd Congress of the Society of French Transfusion Sanguine (SFTS) 2005, June 27, 2005 - June 30, 2005
[ View Abstract]
[ Download Poster PDF]
Comparability of In Vitro Characteristics between INTERCEPT Plasma to Conventional FFP
L Pinkoski, Y Singh, L Corash
Presented at 22nd Congress of the Society of French Transfusion Sanguine (SFTS) 2005, June 27, 2005 - June 30, 2005
[ View Abstract]
[ Download Poster PDF]
A murine model for the prevention of transfusion-transmitted CMV infection
J Roback, L. Lin, L. Corash
Presented at 31st Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), March 20, 2005 - March 23, 2005
[ View Abstract]
Next 10 Abstracts >
|
